Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06185205 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

Study acronym: ASHBY
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: 7 to 8v8
  2. Enrollment target: 120 to 170v7
  3. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v6
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  5. Site contact updatedv4
Show 2 earlier versionsHide 2 earlier versions
  1. Enrollment target: 60 to 120
    • Secondary endpoints: 6 to 7
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 5, 2024 to Dec 12, 2023
    • Interventions: Accelerated partial breast irradiation (Radiation) to Accelerated partial breast irradiation (Drug)
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.
Trial Details
NCT Number NCT06185205
Lead Sponsor Virginia Commonwealth University
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating
Enrollment 170 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov